🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Feng Gao

Washington University in St. Louis

ORCID: 0009-0007-8910-4760

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium”.

Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium

Blood Advances(2023)10.1182/bloodadvances.2023011489

N/A

0.963DataRank · unranked

27 citations

Miriam T. Jacobs, Feng Gao, Loretta J. Nastoupil, Jay Y. Spiegel, Yi Lin +21 more

Idasanutlin and navitoclax induce synergistic apoptotic cell death in T-cell acute lymphoblastic leukemia

Leukemia(2023)10.1038/s41375-023-02057-x

N/A

0.449DataRank · unranked

19 citations

Megan S. Zimmerman, I. V. Dmytrenko, Feng Gao, Daniel C. Link, Kimberly B. Johansson

Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma

Leukemia(2022)10.1038/s41375-022-01691-1

N/A

0.416DataRank · unranked

15 citations

Thomas G. Martin, Nitya Nathwani, Mark A. Fiala, Michael P. Rettig, Feng Gao +10 more

The interim result of a phase I/II study of nivolumab with or without ipilimumab in combination with multi-fraction stereotactic radiosurgery for recurrent, high-grade, radiation-relapsed meningioma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2068

N/A

0.373DataRank · unranked

11 citations

Feng Gao, Joshua S. Shimony, Tanner M. Johanns, Megan Mantica, Timothy R. Gershon +6 more

Phase I dose escalation and expansion study of defactinib, pembrolizumab, and gemcitabine in patients with advanced treatment-refractory pancreatic cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4146

N/A

0.104DataRank · unranked

1 citations

Kian-Huat Lim, Robert R. McWilliams, Rama Suresh, A. Craig Lockhart, Amberly Brown +15 more

The Association of Agent Orange (AO) Exposure with Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma (MM) Progression: A Population-based Study of Vietnam War Era Veterans

Research Square(2023)10.21203/rs.3.rs-3396573/v1

N/A

0DataRank · unranked

0 citations

Mei Wang, Nikhil Grandhi, Mark A. Schroeder, Theodore Thomas, Kristin Vargo +4 more

The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission: a retrospective analysis

Blood(2022)10.1182/blood.2022016194

N/A

0DataRank · unranked

88 citations

Michael Slade, Hagop M. Kantarjian, Julio Alvarenga, Ibrahim Aldoss, Kahee A. Mohammed +16 more

The association of agent orange (AO) exposure with monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma (MM) progression: A population-based study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.8050

N/A

0DataRank · unranked

0 citations

Mei Wang, Mark A. Schroeder, Theodore Thomas, Akhil Kumar, Kristin Vargo +4 more

Clinical characteristics and outcomes of infection with human T-lymphotropic virus in a non-endemic area: a single institution study

Frontiers in Microbiology(2023)10.3389/fmicb.2023.1187697

N/A

0DataRank · unranked

1 citations

Feng Gao, Sneha Poondru, Theodore Thomas, Lee Ratner, Margery Gang

A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity

Nature Communications(2022)10.1038/s41467-022-30860-0

N/A

0DataRank · unranked

97 citations

Reyka G. Jayasinghe, Jessica M. Devenport, Julie Ritchey, Michael P. Rettig, Julie O’Neal +8 more